Abstract
Objective: The risk of congenital syphilis for neonatal hearing loss is currently unclear. In this study we determined the occurrence of risk for hearing loss during follow-up of neonatal hearing screening in infants with congenital syphilis during the first two months of life. Methodology: Prospective cross-sectional study. Automatic auditory brainstem response (AABR) was performed after hospital discharge (nine to 60 days). The sample consisted of 93 newborns in public maternity hospitals, divided into three groups: Exposed to syphilis: seven newborns of mothers who underwent the current best practice treatment for syphilis during the prenatal period after detecting positive for the disease using the Venereal diseases research laboratory (VDRL) exam; Congenital syphilis: 37 newborns and their mothers who received syphilis treatment during the perinatal period, following a positive result of VDRL at birth; Control: 49 newborns of women who had a negative result of VDRL, showing absence of syphilis during pre- and perinatal periods. None of the newborns had other risk indicators for hearing loss. Analysis was based on binary pass/failure in AABR, the standard clinical practice. Results: In the Exposed group, 7/7 newborns (100%) passed the test bilaterally. In the Congenital group, 36/37 (97%) passed the test for the right ear and 35/37 (94%) for the left ear. In the Control group, 47/49 (96%) passed the test for the RE and 46/49 (94%) for the left ear. The proportion of passes did not differ statistically between groups or ears. Conclusion: Neither exposure to syphilis nor the presence of congenital syphilis were indicators of a higher occurrence of neonatal hearing screen failure during the first two months of life.